The impact of Corynebacterium glucuronolyticumon semen parameters: a prospective pre-post-treatment study by Meštrović, Tomislav et al.
 Središnja medicinska knjižnica 
 
This is the peer reviewed version of the following article:  
 
Meštrović T., Bedenić B., Wilson J., Ljubin-Sternak S., Sviben M., Neuberg 
M., Ribić R., Kozina G., Profozić Z. (2018) The impact of Corynebacterium 
glucuronolyticum on semen parameters: a prospective pre-post treatment 
study. Andrology, 6 (1). pp. 223-229. ISSN 2047-2919 
which has been published in final form at http://doi.org/10.1111/cod.12696. This article may 
be used for non-commercial purposes in accordance with Wiley Terms and Conditions for 
Self-Archiving. 
 
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2047-2927 
http://doi.org/10.1111/andr.12453 
http://medlib.mef.hr/3603 
 
 
 
 
 
University of Zagreb School of Medicine Repository 
http://medlib.mef.hr/ 
1 
 
 
Original Research Article 
 
 
 
The impact of Corynebacterium glucuronolyticum on semen 
parameters: a prospective pre-post treatment study 
 
 
 
Authors: 
Tomislav Meštrović1, Branka Bedenić2,3, Jonas Wilson4, Sunčanica Ljubin-Sternak2,5, Mario 
Sviben2,6, Marijana Neuberg7, Rosana Ribić8, Goran Kozina7, Zora Profozić1 
 
 
 
 
 
Affiliations: 
1 Clinical Microbiology and Parasitology Unit, Polyclinic “Dr. Zora Profozić”, Zagreb, Croatia 
2 Medical Microbiology Department, School of Medicine, University of Zagreb, Šalata 3, Zagreb, Croatia 
3 Department of Clinical and Molecular Microbiology, University Hospital Centre Zagreb, Zagreb, Croatia 
4 School of Medicine, University of Zagreb, Šalata 3, Zagreb, Croatia 
5 Clinical Microbiology Department, Teaching Institute of Public Health “Dr Andrija Štampar”, Croatia 
6 Microbiology Service, Croatian National Institute of Public Health, Zagreb, Croatia 
7 Department of Biomedical Sciences, University Centre Varaždin, University North, Varaždin, Croatia 
8 Research and Development Sector, TESLA d.o.o., Ivanec, Croatia 
 
 
 
 
 
Key words: corynebacteria, genital infection, spermatozoa, sperm analysis 
 
Running Title: Corynebacterium glucuronolyticum and semen parameters 
 
2 
 
Abstract 
 
 
Background: Corynebacterium glucuronolyticum (C. glurucornolyticum) is a rare isolate that is 
only recently being acknowledged as a potential urogenital pathogen. The  bibliographic 
references on this bacterial species  are scarce, and its influence on all semen parameters was 
hitherto unknown. 
 
Methods: A prospective approach to compare semen parameters before and after treatment was 
used in this study. C. glucuronolyticum in semen specimens was identified by using analytical 
profile index biotyping system (API Coryne) and additionally confirmed by matrix-assisted laser 
desorption/ionization time-of-flight mass-spectrometry (MALDI-TOF MS), with the 
determination of antimicrobial susceptibility by Kirby–Bauer method. Semen analysis was done 
according to the criteria from the World Health Organization (with the use of Tygerberg method of 
sperm morphology categorization). Very strict inclusion criteria for participants also included 
detailed medical history and urological evaluation. 
 
Results: From a total of 2169 screened semen specimens, the inclusion rate for participants with 
C. glucuronolyticum that satisfied all the criteria was 1.11%. Antibiogram-guided treatment of the 
infection with ensuing microbiological clearance has shown that the resolution of the infection 
correlates with statistically-significant improvement in the vitality of spermatozoa, but also with a 
lower number of neck and mid-piece defects. Parameters such as sperm count, motility and 
normal morphology were not affected. In addition, susceptibility testing revealed a trend towards 
ciprofloxacin resistance. 
 
Conclusions: Albeit it is rarely encountered as a monoisolate in significant quantities, C. 
glucuronolyticum may negatively influence certain sperm parameters; therefore, it has to be taken 
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into account when assessing urogenital samples. 
Introduction 
 
 
Corynebacterium species are a group of Gram-positive bacilli from the class Actinobacteria 
that are increasingly being recognized as opportunistic pathogens [1,2]. They are pleomorphic 
rods without spores and without a capsule that often appear as hieroglyphic clusters in Gram-
stains [3]. Among them, species that found their niche in the urogenital tract are being 
discerned in taxonomic studies [4-7]. Moreover, one rare isolate characteristic for male 
individuals that has been properly acknowledged, quite recently, is Corynebacterium 
glucuronolyticum (C. glucuronolyticum). 
 
This entity was initially regarded as two distinct species (and subsequently named 
Corynebacterium glucuronolyticum and Corynebacterium seminale) [8,9], which was further 
backed by certain metabolic dissimilarities in esculin hydrolysis. However, genotypic 
analyses and the observation of 96–97% DNA homology in strains isolated from patients with 
prostatitis confirmed that it is actually the same species [4,10]. Therefore, nomenclatural 
priority should be given to the name C. glucuronolyticum, albeit the designation C. seminale 
is still commonly encountered in the literature (even in recent publications) – hence, it can be 
considered as a synonym. 
 
Coryneform bacteria (also referred to as “diphteroids”) in urogenital tract have been generally 
regarded as saprophytes, but pathogenic potential of C. glucuronolyticum is becoming 
increasingly evident [11]. Akin to some other studies [11,12], our research group previously 
confirmed its role in male urethritis syndrome [13]; others have shown its potential of causing 
monomicrobial paucisymptomatic bacterial prostatitis [14]. This species may even cause 
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encrusted cystitis without the presence of predisposing factors [15]. 
 
Nonetheless, thus far only a dozen studies on this pathogen can be found in the relevant  
references. One of the reasons is that the identification of coryneform bacteria to the species 
level is usually cumbersome and seldom pursued. There is only one non-prospective, 
comparative study from France that evaluated the potential influence of C. glucuronolyticum 
known that a panoply of different bacterial pathogens may negatively influence semen 
parameters; however, only one study has recently observed the influence of seminal 
coryneform bacteria, as a group, on semen parameters in infertile men, without appraising a 
putative role of distinct species [17]. 
 
Therefore, by employing prospective, pre-post treatment study design with strict 
inclusion/exclusion criteria, our primary aim was to assess whether the presence of C. 
glurucornolyticum, as an etiologically relevant monoisolate, may negatively affect semen 
parameters. Additionally, we wanted to obtain insights into the antimicrobial sensitivity 
profile of isolated strains. 
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Materials and Methods 
 
 
 
Subjects 
 
A total of 2169 male individuals (aged between 18 and 68 years), who visited an outpatient 
clinic for sexually transmitted diseases during a 4-year period (between 2013 and 2017), gave 
their semen specimens for microbiological analysis. Following the initial screening and 
examination of all specimens, only those that exhibited pure-culture growth of C. 
glucuronolyticum, with a large number of colony forming units or CFUs (by employing 
specific microbiological techniques and analyses described below), were submitted for further 
diagnostic workup. All  patients gave their consent to proceed with the investigation for the 
purposes of this study. 
 
A first step was to ascertain the presence or absence of any symptoms of the genitourinary 
tract. After that, each patient’s medical history was used to pinpoint any behavioural patterns 
and/or risk factors that may have a substantial impact on their semen parameters. Such history 
included questions pertaining to childhood diseases, developmental patterns, prior surgeries, 
allergies, systemic medical conditions (like diabetes mellitus), family reproductive history, the 
usage of prescription and non-prescription medications, as well as a review of systems and 
lifestyle exposures. 
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Microbiological workup 
 
The postulates for the sterile collection of semen specimens were given to all individuals as 
instructions prior to sampling. This was done in order to avoid any microbiological 
contamination from potential non-semen sources (such as commensal organisms from the 
skin). The cultivation procedure for all semen specimens entailed the usage of Blood Agar 
Base No. 2 (Oxoid, UK) with 7% defibrinated sheep blood and chocolate agar at 36.7 °C in an 
aerobic atmosphere supplemented with CO2, as well as by using MacConkey and Sabouraud 
agar (Oxoid, UK). White to yellow, non‐haemolytic colonies that grew on blood and 
chocolate agar plates were subjected to Gram-staining, revealing Gram‐positive, non-spore-
forming bacilli in a distinguishing ‘Chinese letters’ arrangement. A positive CAMP reaction 
with staphylococcal β‐haemolysin was seen after incubation at 36.7 °C for 24 hours. 
Subsequently, the final identification of the microorganism as C. glucuronolyticum was done 
by using analytical profile index biotyping strip system – API Coryne (bioMérieux, France). 
 
Only those individuals whose specimens yielded C. glucuronolyticum in pure-culture (without 
the presence of any other isolates) and with colony counts larger than 104 CFU/mL were 
submitted for further diagnostic workup. These isolates (originally confirmed by API Coryne) 
were additionally confirmed by using matrix-assisted laser desorption/ionization time-of-
flight mass-spectrometry (MALDI-TOF MS) (MicroflexTM MALDI Biotyper MS, Bruker-
Daltonik, Fremont, CA), and these two techniques showed complete correlation. The presence 
of other aerobic urogenital pathogens that may influence semen parameters (such as Neisseria 
gonorrhoeae, Escherichia coli, Enterococcus faecalis, etc.), as well as the presence of 
sexually-transmitted pathogens (such as Chlamydia trachomatis, Ureaplasma spp., 
Mycoplasma hominis, Trichomonas vaginalis), was excluded by employing appropriate 
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microbiological diagnostic procedures. 
 
Antimicrobial susceptibility was performed by using agar disk diffusion or Kirby–Bauer 
method [18], according to the EUCAST (European Committee on Antimicrobial 
Susceptibility Testing) guidelines and breakpoint tables [19]. Approximately 4–5 colonies of 
C. glucuronolyticum were inoculated in 5 ml of nutrient broth and subsequently incubated for 
up to 8 hours, until the suspension matched McFarland 0.5 turbidity standard. Those 
suspensions were then spread over Müller-Hinton agar plates (Oxoid, UK), followed by the 
placement of applicable antimicrobial discs and incubation in an aerobic environment at 
36.7 °C for 24 hos. The inhibition zones were then measured in millimetres and compared to a 
standard interpretation chart in order to categorize the isolates as susceptible, intermediate 
susceptible, or resistant. 
 
 
Semen analysis 
 
In further diagnostic workup, every participant was given clearly written and verbal 
instructions regarding the proper collection of the semen sample and was provided with a 
clean, wide-mouthed container made of plastic that is non-toxic for spermatozoa. Semen 
samples were collected by masturbation after 3-5 days of abstinence from sexual activity, with 
the initial analysis ensuing soon after liquefaction (30 minutes at 36.7 °C). The concentration 
of inflammatory cells (leukocytes) was calculated relative to spermatozoa by appraising fixed 
and stained smears made from undiluted semen. 
 
The analysis was done by employing methods recommended by the World Health 
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Organization (WHO) [20]. Semen volume was measured by transferring the sample directly 
into a commercial graduated glass measuring cylinder with a wide mouth. The pH was 
measured by using pH paper (Merck KgaG, Germany) that was checked against known 
standards. Total sperm number was calculated by using the Makler counting chamber (Sefi 
Medical Instruments Ltd., Israel) with 5 µL of well-mixed semen. In order to measure total 
motility, the parameters of progressive motility, non-progressive motility and immotile 
spermatozoids were measured at room temperature. 
 
Sperm vitality was determined with the exclusion of vital dye (i.e. eosin) from spermatozoid 
head membranes by using a one-step staining technique with eosin–nigrosin; these results 
were confirmed with the help of the hypo-osmotic swelling (HOS) test. Papanicolaou staining 
procedure was used to prepare slides for sperm morphology assessment, and in the analysis a 
strict (or Tygerberg) method of categorization was used. Alongside measuring the percentage 
of normal forms, the percentage of head, neck, mid-piece and tail defects, as well as excess 
residual cytoplasm (ERC), were also noted. 
 
In order to distinguish normal semen specimens from abnormal ones, the WHO’s lower 
reference limits were used for threshold values. Normal specimens were characterized by 
normozoospermia. This meant that the values of three pivotal sperm parameters (number, 
motility and morphology) were above the threshold as described by the WHO. Abnormal 
specimens showed deviations from the references for one or more of the aforementioned 
parameters – resulting in oligozoospermia when number was affected, asthenozoospermia 
when motility was affected, and teratozoospermia when morphology was affected (or a 
combination of these semen quality issues). 
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Urological examination 
 
A urological examination was conducted on each subject, with a special focus on the genitalia, 
which included examination of the penis and the urethral meatus, palpation and measurement 
of the testes, and the eventual presence (and consistency) of both the epididymis and vasa. 
Also included in the exam was the identification of palpable varicoceles, as well as the 
appraisal of secondary sex characteristics (such as body habitus and hair distribution). In 
addition to the extensive physical examination, scrotal colour Doppler ultrasonography was 
performed on all patients to exclude the possible presence of varicocele or testicular tumours. 
Furthermore, for approximate measurement of prostate dimension and volume, suprapubic 
ultrasonography was pursued. Philips ClearVue 650 ultrasound machine with Active Array 
technology was used for all ultra-sonographic examinations (Philips, Netherlands). 
 
 
Patients participating in treat/re-test study protocol 
 
From the 35 individuals with C. glucuronolyticum > 104 CFU/mL, nine of them were 
excluded from the further study protocol due to the presence of co-infecting agents. Two 
additional individuals were excluded due to the presence of varicocele and previous 
radiotherapy. Each of the remaining 24 study participants with C. glucuronolyticum > 104 
CFU/mL and in pure culture was treated according to the antibiogram results of the isolate in 
question, after providing a semen sample for semen analysis. Microbiological clearance after 
treatment was tested one week, one month and two months after treatment by using culturing 
techniques (as described previously). A control semen specimen for semen analysis and final 
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microbiological clearance confirmation was tested three months after the treatment. Two 
participants did not return for a control semen analysis; thus, they were not included in the 
final analysis. Each semen specimen was blinded from the biomedical engineer doing the 
sperm analysis in order to prevent researcher bias, and the same person did all of the analyses 
in order to avoid inter-rater reliability issues. 
 
 
Statistical analysis 
 
The obtained data was double entered into Excel sheets and exported to Statistical Package 
for Social Sciences version 17 for subsequent analysis (SPSS Inc., USA). Descriptive 
statistics, including means, medians and standard deviations, were calculated for variables as 
appropriate. A paired t-test (dependent sample t-test) and analysis of partial correlations were 
employed in the analysis (their use is further justified in the “Results” section for the sake of 
clarity). A p-value of less than 0.05 was considered statistically significant. 
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Results 
 
 
From a total of 2169 semen specimens screened, 498 of them (22.96%) revealed growth of 
coryneform bacteria (with a majority of them displaying colony counts smaller than 104 
CFU/mL). C. glucuronolyticum in pure culture and with colony counts larger than 104 
CFU/mL was established in 35 of semen specimens (1.61%). After applying all the above-
mentioned rigorous inclusion and exclusion criteria, as well as ruling out co-infections, a total 
of 24 individuals (age range from 21 to 52 years with mean age of 35 and median age 34) 
constituted our cohort group in this study (1.11%). MALDI-TOF MS for final confirmation of 
these isolates has shown 100% concurrence with API Coryne system. Semen analysis (in line 
with the WHO criteria) was pursued in study participants before they were subjected to 
antimicrobial therapy according to the respective antibiogram results. 
 
Generally, isolated strains of C. glucuronolyticum showed excellent sensitivity to rifampicin 
and vancomycin (100% of strains susceptible), very good sensitivity to penicillin G and 
gentamicin (97.14% and 91.43% of strains susceptible, respectively), modest sensitivity to 
ciprofloxacin (68.57% of strains susceptible) and low susceptibility to tetracycline and 
clindamycin (45.71% and 40% of strains susceptible, respectively) (Figure 1). Post-treatment 
semen analysis was done three months after a successful course of therapy (with 
microbiological confirmation of bacteriological clearance). Before treatment, five individuals 
presented with frank symptoms of urethritis and/or prostatitis, whereas after treatment the 
symptoms persisted in only one of them. 
 
As a part of prospective study approach, comparisons were then made between the semen 
parameters of individuals before and after the treatment. In the pre-treatment group there were 
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15 normal semen specimens (i.e. normozoospermia) and 9 abnormal ones (i.e. those with 
oligozoospermia, asthenozoospermia, teratozoospermia or a combination), according to the 
WHO criteria. After treatment just one of the abnormal specimens reverted to the normal 
group (i.e. all parameters were now within normal ranges), while the opposite was not 
observed. Leukocytospermia was present in 7 specimens before treatment, whereas after 
treatment it was present in 3 specimens. However, in order to reveal the true influence of 
treatment (and consequently of C. glucuronolyticum) on specific seminal parameters, precise 
statistical analyses were performed on both normal and abnormal group of semen specimens. 
 
A summary of descriptive data for pre-treatment and post-treatment sperm parameters is 
presented in Table 1, while detailed breakdown of their sperm morphology is presented in 
Table 2. Regarding the morphology subcategories, by applying t-test for paired samples, there 
was a statistically significant difference in the number of spermatozoa with neck and mid-
piece aberrations in the group of normal semen specimens (p < 0.001); more specifically, 
although the parameters in this group were generally within reference values, there were 
significantly less neck and mid-piece defects after treating the infection than before the 
treatment. Conversely, there were no statistically significant differences in the number of 
normal forms of spermatozoa, those with aberrant heads or tails, or those with ERC for either 
of the two groups of semen specimens (p > 0.05). 
 
Data summary in Table 1 may point to the conclusion that practically all parameters 
marginally improved after treatment. In order to properly ascertain whether treating the 
infection with C. glucuronolyticum actually had any statistically significant influence on 
semen parameters, a stringent partial correlation analysis was pursued (Table 3, Table 4). 
Consequently, control variables, such as participant’s age, days of abstinence, seminal pH 
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value and leukocytospermia, were not included in the regression analysis due to the low ratio 
of participant number and predictors (df=18). The results have shown that in the pre-treatment 
group there was a marginal difference between normal and abnormal semen specimens 
regarding the total sperm concentration (r = 0.46, p = 0.044), whilst more significant 
differences have been observed in total motility (r = -0.80, p < 0.001) and vitality (r = -0.57, p 
= 0.009). On the other hand, in the post-treatment group there was again a marginal difference 
between normal and abnormal semen specimens regarding the total sperm concentration (r = -
0.48, p = 0.044), and significant difference in total motility only (r = -0.56, p = 0.015), 
whereas the correlation with vitality was not significant anymore. 
 
In other words, the latter analysis revealed that, when participant’s age, days of abstinence, 
seminal pH value and leukocytospermia are taken into account, a statistically significant 
increase of spermatozoa vitality can be observed after the treatment of C. glucuronolyticum. 
Other analysed parameters (more precisely sperm count, motility and normal morphology) 
were not influenced by the treatment and ensuing microbiological clearance. 
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Figure 1. Antimicrobial susceptibility of C. glucuronolyticum from semen specimens 
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Table 1. Grouped descriptive statistics of the semen parameters before and after the treatment 
and microbiological clearance of C. glucuronolyticum (Note: *SD stands for standard 
deviation) 
 
  
  
Mean Median SD 
 
Mean Median SD 
Abstinence (Days) 
Before 
Treatment 
3.58 3.00 0.72 
After 
Treatment 
3.55 3.50 0.60 
pH 7.46 7.50 0.30 7.47 7.50 0.25 
Sperm Count 52.03 48.50 37.64 55.45 47.00 34.79 
Total Motility 50.79 52.50 14.76 53.00 56.50 13.65 
Vitality 70.79 71.50 8.55 72.86 73.00 6.50 
Normal Morphology 16.92 17.00 6.65 18.09 17.00 5.69 
 
 
 
 
Table 2. Grouped descriptive statistics of the spermatozoa morphology before and after the 
treatment and microbiological clearance of C. glucuronolyticum (Note: *SD stands for 
standard deviation; SEM stands for standard error of the mean; ERC stands for excess 
residual cytoplasm) 
 
  
  
Mean SD SEM 
 
Mean SD SEM 
Normal morphology 
Before 
Treatment 
16.92 6.65 1.36 
After 
Treatment 
18.09 5.69 1.21 
Head defects 70.42 5.29 1.08 71.05 4.34 0.92 
Neck defects 22.75 4.69 0.96 18.86 3.88 0.83 
Tail defects 11.29 2.35 0.48 11.59 2.32 0.50 
ERC 2.25 0.79 0.16 2.41 0.73 0.16 
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Table 3. Partial correlation analysis of sperm parameters before the treatment (Note: *p-value 
< 0.05; **p-value < 0.01; ***p-value < 0.001)  
 
 
Sperm count Motility Vitality Morphology 
Category -0.46* -0.80*** -0.57** -0.17 
Sperm count 
 
0.34 0.10 0.04 
Motility 
  
0.36 0.15 
Vitality 
   
0.02 
 
 
 
 
Table 4. Partial correlation analysis of sperm parameters after the treatment (Note: *p-value < 
0.05; **p-value < 0.01) 
 
 
Sperm count Motility Vitality Morphology 
Category -0.48* -0.56* -0.29 -0.08 
Sperm count 
 
0.31 0.38 0.05 
Motility 
  
0.65** 0.13 
Vitality 
   
0.06 
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Discussion 
 
 
This is the first study in the medical literature that aimed to assess whether the presence of 
specific corynebacterial species (in this case C. glurucornolyticum) in monoculture with 
established etiological relevance may negatively affect all important semen parameters, and 
the results have shown a negative influence on the vitality and neck morphology of 
spermatozoa. However, sperm parameters that are considered more important (such as 
number and motility) were not adversely affected, i.e. there were no statistically significant 
changes following the treatment and microbiological clearance. Albeit our results could 
consequently point to a minor influence of this species on semen parameters, vitality can be a 
pivotal parameter when the motility of spermatozoids in semen sample is low [20]. 
 
The strengths of our study are a prospective study design, strict inclusion/exclusion criteria 
for study participants, detailed microbiological workup to ensure clinical significance and 
conclusive confirmation of the isolates, individually tailored treatment regimens according to 
the respective antibiograms, methodological sturdiness in semen evaluation, a three-month 
interval between pre-treatment and post-treatment semen analysis, as well as stringent 
statistical analysis. Conversely, the main weakness of our study would be the number of 
included study participants; however, to our knowledge this is the largest collection of C. 
glucuronolyticum isolates from semen specimens with colony counts > 104 CFU/mL (and 
purported etiological relevance) in a single study. 
 
In our study, corynebacteria as a group were found in 22.96% of all specimens. Still, it must 
be noted that in a majority of those samples their colony count was less than 104 CFU/mL and 
they grew alongside other saprophytes of the distal urethra. On the other hand, after pursuing 
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species-level identification in specimens with more than 104 CFU/mL, C. glucuronolyticum in 
significant numbers was found in only 1.61% of all specimens. Antimicrobial susceptibility 
testing was done in all those isolates (Figure 1), but only those without any co-infection and 
those who satisfied strict inclusion criteria were included in a further prospective study 
protocol (1.11%). Therefore, coryneform bacteria may be commonly encountered in semen 
specimens (with a quite variable span from 12% up to 86.6% in studies conducted by different 
research groups) [17,21,22], but probably only a small fraction of them are to be considered 
clinically relevant. 
 
When it comes to the sensitivity of the isolates, this study revealed considerable resistance to 
clindamycin and tetracycline, as well as a trend toward ciprofloxacin resistance. The latter 
finding is particularly worrisome, as fluoroquinolones are often a treatment cornerstone and a 
sort of wild card in urology practice, as well as the most habitually administered drug for 
urinary tract infections in men from Croatia [23]. A similar susceptibility pattern has been 
demonstrated by Mashaly and his co-authors on the isolates from Egypt (albeit with less 
quinolone resistance) [17], whereas Funke et al. have shown that MIC50 values were highest 
for chloramphenicol, clindamycin and tetracycline [24]. 
 
The exact instances when the usual commensals (like corynebacteria) of the male genital tract 
may act as pathogens represent a good question without a good answer, as elegantly stated by 
Türk et al. [25]. We recently described a ciprofloxacin-resistant strain that caused male 
urethritis syndrome [13], which is a clinical presentation described by other research groups 
as well [11,12]. Moreover, this entity may be responsible for the encrustation of the bladder 
mucosa with subsequent chronic inflammation (also known as encrusted cystitis), as 
described by Curry and her colleagues [15]. 
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Contrarily, association of this species with prostatitis syndrome is not so straightforward. 
Novo-Veleiro et al. highlighted the potential significance of C. glucuronolyticum in three 
patients with monomicrobial paucisymptomatic infectious prostatitis with a fever of unknown 
origin [14]. However, although coryneform species were more abundant in prostatitis patients 
when compared to controls in the recent paper by Türk et al., from five molecularly-
confirmed C. glucuronolyticum species they have described, none have shown the propensity 
to form biofilms in the prostate gland [25]. 
 
The current estimations are that 15% of infertility in men is linked to genital tract infection 
[26]. For example, some studies suggest that exposure to Chlamydia trachomatis may affect 
sperm function and induce premature sperm death [27,28]. Furthermore, a recent systematic 
review and meta-analysis conducted by Huang et al. showed that Ureaplasma urealyticum 
and Mycoplasma hominis are significantly associated with male infertility [29], and various 
research groups have shown that these two pathogens are associated lower sperm 
concentrations motility, vitality, density, as well as with higher semen viscosity [30]. A 
plethora of other bacterial species (not necessarily sexually-transmitted) may also potentially 
alter sperm quality [31]. 
 
However, sporadic detection of this microorganism in clinically relevant numbers (partly due 
to infrequent species-level identification of coryneform bacteria) is probably a reason why 
this species has not been thoroughly studied in similar clinical-microbiological research 
endeavours. Mashaly et al. examined the influence of seminal coryneforms as a group on 
semen parameters in infertile men, and showed that sperm motility was lower in those with 
the presence of any coryneforms [17]. But from 12 semen cultures that harboured 
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Corynebacterium species they identified four different genus representatives, which hinders 
adequate conclusions; moreover, they did not look at sperm vitality or more detailed 
morphology parameters. 
 
In the study by Riegel and Lepargneur [16] there were 2.7% of C. glucuronolyticum isolates 
in the sample of 1902 patients with colony counts greater than 103 CFU/mL. These authors 
compared the values of only two semen parameters (i.e. total motility and pH) in samples with 
aforementioned numbers of C. glucuronolyticum with the values in semen samples harbouring 
identical numbers of other corynebacteria. The results have shown that normal spermatozoid 
motility was found in 25.4% of samples with high C. glucuronolyticum counts, when 
compared to 45% of specimens containing similar counts of other corynebacteria. However, 
there is a myriad of methodological issues with this study, as the authors did not account for 
the eventual presence of other potential co-infections, there were no inclusion/exclusion 
criteria, no other examinations conducted, no prospective follow-up, and colony count cut-off 
value was not high enough to discriminate between colonization and infection. 
 
An inherent problem with a large number of studies in this field is that culture-positive and 
culture-negative groups are compared without any type of therapeutic intervention or 
prospective follow-up, which is why we opted for a different, pretest-posttest approach. 
Nonetheless, there is still an issue of intra-individual variation in semen composition, which is 
also something that should always be taken ’cum grano salis’ when interpreting all studies 
exploring how particular pathogens influence semen parameters [20]. An overly short time 
interval before the re-evaluation may also be an issue, thus we used a three-month time frame 
to fully account for the entire process of spermatogenesis and transport on ductal system [32]. 
Also, antibiotic therapy may not always prevent permanent abnormalities of sperm parameters, 
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likely due to the initiation of persistent immuno-pathological cascades in the genital tract [33]. 
 
But by employing rigorous methodology, certain insights can be gained by these types of 
correlational studies, which is why they are increasingly being conducted. The question then 
remains what are the underlying pathophysiological mechanisms that result in reduced semen 
parameters and (in the worst-case scenario) give rise to infertility. Some authors concentrate 
only on the induction of necrosis and apoptosis [34], while others propose the putative role of 
antigenic mimicry that may exists between certain components of spermatozoa and bacterial 
proteins [31]. Although thus far such cross-reaction has been proved only for the flagella of 
spermatozoa by Moretti et al. [31], our study hints that other parts of spermatozoa may be 
affected as well. 
 
In conclusion, as infertility is becoming a global public health issue with an increasing need 
for assisted reproduction, even mild issues with semen quality can be paramount when 
deciding how to approach a sub-fertile or infertile couple. A meticulous andrological workup 
is warranted, and the presence of corynebacteria in a semen sample should always raise the 
suspicion of C. glucuronolyticum, as this species may exhibit adverse effects on spermatozoa. 
Future studies should address this topic even further to provide new revelations on the 
potential pathophysiological mechanisms. In any case, re-evaluating sperm characteristics 
after treatment is pivotal for reliable assessment of male fertility and confirmation of this 
microorganism’s role in generating defective spermatozoa. 
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